Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TGF‑β1 affects the renal cancer miRNome and regulates tumor cells proliferation. | Int J Mol Med | 2022 | 35179216 | PubTator, text mining | PubMed |
| Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression. | Nat Commun | 2022 | 35173168 | PubTator, text mining | PubMed |
| m6A modification: recent advances, anticancer targeted drug discovery and beyond. | Mol Cancer | 2022 | 35164788 | PubTator, text mining | PubMed |
| MicroRNA let-7 and viral infections: focus on mechanisms of action. | Cell Mol Biol Lett | 2022 | 35164678 | PubTator, text mining | PubMed |
| Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. | Int J Mol Sci | 2022 | 35163592 | PubTator, text mining | PubMed |
| The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases. | Int J Mol Sci | 2022 | 35163477 | PubTator, text mining | PubMed |
| MicroRNAs miR-451a and Let-7i-5p Profiles in Circulating Exosomes Vary among Individuals with Different Sickle Hemoglobin Genotypes and Malaria. | J Clin Med | 2022 | 35159951 | PubTator, text mining | PubMed |
| Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer. | Theranostics | 2022 | 35154471 | PubTator, text mining | PubMed |
| RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma. | Front Genet | 2022 | 35154270 | PubTator, text mining | PubMed |
| Follistatin promotes LIN28B-mediated supporting cell reprogramming and hair cell regeneration in the murine cochlea. | Sci Adv | 2022 | 35148175 | PubTator, text mining | PubMed |
| The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma. | Cancer Cell Int | 2022 | 35135529 | PubTator, text mining | PubMed |
| Genetic Analysis in African American Children Supports Ancestry-Specific Neuroblastoma Susceptibility. | Cancer Epidemiol Biomarkers Prev | 2022 | 35131881 | PubTator, text mining | PubMed |
| Micro RNAs as potential biomarkers in tuberculosis: A systematic review. | Noncoding RNA Res | 2022 | 35128217 | PubTator, text mining | PubMed |
| Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets. | Cancer Sci | 2022 | 35112433 | PubTator, text mining | PubMed |
| Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation. | J Exp Clin Cancer Res | 2022 | 35109899 | PubTator, text mining | PubMed |
| RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. | Oncogene | 2022 | 35102250 | PubTator, text mining | PubMed |
| RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment. | J Transl Med | 2022 | 35062979 | PubTator, text mining | PubMed |
| circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR-520c-3p/methyl-DNA-binding domain protein 2 axis. | Clin Transl Med | 2022 | 35051313 | PubTator, text mining | PubMed |
| The Prognostic Role of m6A-Related Genes in Paediatric Neuroblastoma Patients. | Comput Math Methods Med | 2022 | 35047058 | PubTator, text mining | PubMed |
| Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression. | Oxid Med Cell Longev | 2022 | 35035655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=31